Axsome Therapeutics, Inc (AXSM) is a publicly traded Healthcare sector company. As of May 21, 2026, AXSM trades at $231.00 with a market cap of $11.70B and a P/E ratio of -61.59. AXSM moved +1.82% today. Year to date, AXSM is +34.48%; over the trailing twelve months it is +112.85%. Its 52-week range spans $75.56 to $235.92. Analyst consensus is strong buy with an average price target of $261.88. Rallies surfaces AXSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Axsome Therapeutics, Inc (AXSM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AXSM moved +1.82% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $231.00 |
| Market Cap | $11.70B |
| P/E Ratio | -61.59 |
| EPS | $-3.72 |
| Dividend Yield | 0.00% |
| 52-Week High | $235.92 |
| 52-Week Low | $75.56 |
| Volume | 7 |
| Avg Volume | 0 |
| Revenue (TTM) | $708.24M |
| Net Income | $-188.30M |
| Gross Margin | 0.00% |
19 analysts cover AXSM: 0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $261.88.